GlassScriptPhysician profile
Michelle Gainty
NPI 1437531621
$870.97
in general payments reported to CMS, 2019-2025
8 companies · $413 in 2025
The $413 reported for 2025 was more than what 76% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $34.14 · 2024: $424 · 2025: $413.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $871.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $870.97 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sumitomo Pharma America, INC. | $379.71 | 2024-2025 | Myfembree, Gemtesa |
| Astellas Pharma US INC | $181.02 | 2024-2025 | Veozah |
| Millicent US INC | $74.64 | 2025 | Femlyv, Femring, Intrarosa |
| Bayer Healthcare Pharmaceuticals INC. | $72.24 | 2024-2025 | |
| Exeltis, USA INC. | $59.01 | 2023-2025 | Slynd |
| Hologic Sales and Service, LLC | $42.96 | 2023-2024 | Aptima, Thinprep 2000 Processor |
| Novo Nordisk INC | $38.31 | 2024-2025 | Wegovy |
| Smith+Nephew, INC. | $23.08 | 2024 | Pico |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michelle Gainty listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.